David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OSG
2501
Octave Specialty Group
OSG
$207M
| $2.38M | ﹤0.01% |
335,647
-75,823
| -18% | -$565K |
|
2502
CALL
Kadant
KAI
$3.61B
| $2.38M | ﹤0.01% |
+7,500
| New | +$2.35M |
|
2503
East-West Bancorp
EWBC
$17.9B
| $2.38M | ﹤0.01% |
+23,548
| New | +$2.09M |
|
2504
Prothena Corp
PRTA
$475M
| $2.38M | ﹤0.01% |
391,495
+373,692
| +2,099% | +$2.8M |
|
2505
Unum
UNM
$14.5B
| $2.37M | ﹤0.01% |
29,338
+3,478
| +13% | +$275K |
|
2506
PUT
ArcelorMittal
MT
$56.2B
| $2.37M | ﹤0.01% |
75,000
| – | – |
|
2507
Fastenal
FAST
$58.7B
| $2.37M | ﹤0.01% |
56,318
-117,268
| -68% | -$4.76M |
|
2508
COPT Defense Properties
CDP
$4.23B
| $2.36M | ﹤0.01% |
85,458
-94,110
| -52% | -$2.55M |
|
2509
PUT
AST SpaceMobile
ASTS
$18B
| $2.35M | ﹤0.01% |
50,300
-229,700
| -82% | -$6.65M |
|
2510
Bilibili
BILI
$6.76B
| $2.35M | ﹤0.01% |
109,496
-133,174
| -55% | -$2.45M |
|
2511
PUT
Emerson Electric
EMR
$88.3B
| $2.35M | ﹤0.01% |
17,600
+4,800
| +38% | +$551K |
|
2512
Scotiabank
BNS
$114B
| $2.34M | ﹤0.01% |
42,290
-28,028
| -40% | -$1.43M |
|
|
YMAB
2513
DELISTED
Y-mAbs Therapeutics
YMAB
| $2.33M | ﹤0.01% |
516,857
-32,809
| -6% | -$147K |
|
2514
PUT
Camping World
CWH
$672M
| $2.33M | ﹤0.01% |
135,500
+122,200
| +919% | +$1.91M |
|
|
LADR
2515
Ladder Capital
LADR
$1.25B
| $2.33M | ﹤0.01% |
216,641
+113,308
| +110% | +$1.19M |
|
2516
First Financial Bankshares
FFIN
$4.83B
| $2.33M | ﹤0.01% |
64,707
+8,582
| +15% | +$297K |
|
2517
FIVE9
FIVN
$2.39B
| $2.33M | ﹤0.01% |
87,847
+38,522
| +78% | +$1M |
|
2518
Digi International
DGII
$2.89B
| $2.33M | ﹤0.01% |
66,729
-17,169
| -20% | -$525K |
|
2519
PUT
Advance Auto Parts
AAP
$2.66B
| $2.32M | ﹤0.01% |
50,000
-84,700
| -63% | -$3.39M |
|
2520
iShares US Home Construction ETF
ITB
$2.27B
| $2.32M | ﹤0.01% |
+24,864
| New | +$2.27M |
|
2521
CALL
Array Technologies
ARRY
$725M
| $2.31M | ﹤0.01% |
+391,700
| New | +$2.38M |
|
2522
Usana Health Sciences
USNA
$253M
| $2.31M | ﹤0.01% |
75,616
-71,032
| -48% | -$2.02M |
|
2523
PUT
Olin
OLN
$2B
| $2.31M | ﹤0.01% |
114,900
+2,100
| +2% | +$43.6K |
|
2524
CALL
iQIYI
IQ
$948M
| $2.3M | ﹤0.01% |
+1,300,000
| New | +$2.34M |
|
2525
iShares MSCI Sweden ETF
EWD
$765M
| $2.3M | ﹤0.01% |
50,294
-1,107
| -2% | -$48.6K |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.